This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

EU reaches agreement on crisis licensing bill

( May 22, 2025, 07:34 GMT | Official Statement) -- MLex Summary: EU lawmakers and member states have agreed on legislation establishing a compulsory licensing regime that allows the production of patented crisis-relevant products, such as vaccines or microchips, without the patent holder’s consent during emergencies. The European Commission would be empowered to grant such licenses under defined conditions, ensuring compensation for rights holders and imposing penalties for non-compliance by licensees. The bill will need a final stamp of approval in a vote from the European Parliament and Council of the EU before it can enter the EU Official Journal.Below is the press release from the European Parliament's legal affairs committee....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections